XAURON Trademark

Trademark Overview

On Thursday, February 8, 2024, a trademark application was filed for XAURON with the United States Patent and Trademark Office. The USPTO has given the XAURON trademark a serial number of 98397990. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Wednesday, January 28, 2026. This trademark is owned by Pedra Technology Pte. Ltd.. The XAURON trademark is filed in the Medical Instrument Products category with the following description:

medical devices for use in diagnosing or treating diseases that affect blood flow; medical devices for use in measuring blood perfusion characteristics
xauron

General Information

Serial Number98397990
Word MarkXAURON
Filing DateThursday, February 8, 2024
Status731 - SECOND EXTENSION - GRANTED
Status DateWednesday, January 28, 2026
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 17, 2024

Trademark Statements

Goods and Servicesmedical devices for use in diagnosing or treating diseases that affect blood flow; medical devices for use in measuring blood perfusion characteristics

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateThursday, February 8, 2024
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePedra Technology Pte. Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSingapore 109349
SG
Party NamePedra Technology Pte. Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSingapore 109349
SG

Trademark Events

Event DateEvent Description
Thursday, February 8, 2024NEW APPLICATION ENTERED
Friday, June 7, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 3, 2024ASSIGNED TO EXAMINER
Tuesday, September 3, 2024NON-FINAL ACTION WRITTEN
Tuesday, September 3, 2024NON-FINAL ACTION E-MAILED
Tuesday, September 3, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, November 19, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, November 19, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, November 19, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 20, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 11, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 17, 2024PUBLISHED FOR OPPOSITION
Tuesday, December 17, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 11, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 14, 2025SOU TEAS EXTENSION RECEIVED
Monday, July 14, 2025SOU EXTENSION 1 FILED
Monday, July 14, 2025SOU EXTENSION 1 GRANTED
Tuesday, July 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 28, 2026SOU TEAS EXTENSION RECEIVED
Wednesday, January 28, 2026SOU EXTENSION 2 FILED
Wednesday, January 28, 2026SOU EXTENSION 2 GRANTED
Thursday, January 29, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

xauron medical blood devices measuring perfusion characteristics flow affect diagnosing treating